Selected article for: "excessive inflammatory response and inflammatory response"
Author: Parlakpinar, Hakan; Polat, Seyhan; Acet, Hacı Ahmet
Title: Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin
  • Cord-id: rx1k9hu5
  • Document date: 2020_7_13
    • ID: rx1k9hu5
    Snippet: Coronavirus disease 2019 (COVID‐19) is a life‐threatening infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 pandemic causing morbidities and even deaths worldwide revealed that there is urgent need to find pharmacological agents or vaccines. Although there are a lot of agents under investigation, there is no approved agent for the prevention or treatment of the COVID‐19 yet. Treatment of patients remains mainly supportive
    Document: Coronavirus disease 2019 (COVID‐19) is a life‐threatening infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 pandemic causing morbidities and even deaths worldwide revealed that there is urgent need to find pharmacological agents or vaccines. Although there are a lot of agents under investigation, there is no approved agent for the prevention or treatment of the COVID‐19 yet. Treatment of patients remains mainly supportive as well as compassionate use of the agents under investigation. It is well established that excessive inflammatory and immune response as well as oxidative injury play a critical role in the pathogenesis of COVID‐19. In this review, we aimed to update knowledge about pathogenesis, clinical features and pharmacological treatment of COVID‐19 and review the potential beneficial effects of ancient antioxidant, anti‐inflammatory and immunomodulatory molecule melatonin for prevention and treatment of COVID‐19.

    Search related documents:
    Co phrase search for related documents
    • ac adenylyl cyclase and lung injury: 1
    • ace expression and acute pancreatitis: 1, 2, 3
    • ace expression and liver failure: 1
    • ace expression and liver function: 1, 2
    • ace expression and liver injury: 1, 2, 3
    • ace expression and lung affect: 1, 2, 3, 4, 5
    • ace expression and lung damage: 1
    • ace expression and lung disease: 1, 2
    • ace expression and lung edema: 1, 2, 3
    • ace expression and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • ace homologue and liver injury: 1, 2, 3
    • ace homologue and lung disease: 1, 2, 3, 4, 5
    • ace homologue and lung edema: 1, 2
    • ace homologue and lung injury: 1, 2, 3, 4, 5, 6, 7, 8